AKT1 and cancer: Another perspective is that PTEN’s ability to dephosphorylate PIP3 to PIP2 inhibits AKT-regulated downstream signaling events, thereby suppressing the PI3K/AKT pathway32 which is one of the most frequently activated pathways in human cancers.